Harrow's stock (HROW, Financial) experienced a significant decline of nearly 24%, trading at $39.46. The decrease was attributed to the company's third-quarter core net loss of $0.05 per diluted share, which, although an improvement from last year's $0.09 loss per share, fell short of analysts' expectations for normalized earnings of $0.07 per share.
The company's revenue for the quarter reached $49.3 million, surpassing the previous year's $34.3 million but still underperforming against analysts' projection of $52.8 million. These financial results contributed to the stock's pre-market decline.